Shawn Leland

Shawn Leland

Company: Elevation Oncology

Job title: Founder & Chief Executive Officer


NRG1 Fusions: A Tumor-Agnostic Oncogenic Driver 11:50 am

Genomic alterations fall on a spectrum of oncogenic potential. “True” oncogenic driver alterations are optimal biomarkers for targeted therapy development in precision oncology NRG1 fusions are emerging as “true” oncogenic driver alterations that can be found across solid tumor types and are enriched in certain NSCLC populations such as IMA NRG1 fusions may be therapeutically…Read more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.